Kevetrin P1 QofL (I take that to mean Quality of L
Post# of 72440
What other cancer drug working with any cancer patients, much less terminal patients that are in the most fragile state of being, have you heard of that didn't reach any negative physical end points?
This fact alone should have ramped Kevetrin to a platform position in the world of cancer research, especially when it showed the potential to be a complementary star when working with most other current cancer treatments. Case in point, the reduction of tumors in renal cancer(?) where no reductions prior had ever been seen.
Makes me wonder why so many bright doctors didn't figure this out?